Rhythm Biosciences Limited (FRA:0RY)
Germany · Delayed Price · Currency is EUR 0.0505
-0.0020 (-3.81%)
Last updated: Oct 21, 2025, 9:59 AM CET
Rhythm Biosciences Company Description
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States.
It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development.
The company was incorporated in 2017 and is headquartered in Parkville, Australia.
Rhythm Biosciences Limited
| Country | Australia |
| Founded | 2017 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| CEO | David Atkins |
Contact Details
Address: Bio21 Institute Parkville, 3010 Australia | |
| Phone | 61 3 8256 2880 |
| Website | rhythmbio.com |
Stock Details
| Ticker Symbol | 0RY |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| David Atkins | Chief Executive Officer |
| Todd Perkinson | Chief Financial Officer |